We are live on ! Find out more
TC

Truvestments Capital Portfolio holdings

AUM $554M
1-Year Est. Return 32.49%
This Fund
S&P 500
This Quarter Est. Return
+13.44%
1 Year Est. Return
+32.49%
3 Year Est. Return
+86.71%
5 Year Est. Return
+90.42%
10 Year Est. Return
–
AUM
$500M
AUM Growth
+$39.5M
Cap. Flow
-$1.25M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.84%
Holding
1,111
New
66
Increased
187
Reduced
301
Closed
121

Top Buys

Rank Stock Value
1
MSTR icon
Strategy Inc
MSTR
+$1.88M
2
IBIT icon
iShares Bitcoin Trust
IBIT
+$1.45M
3
ETHA
iShares Ethereum Trust ETF
ETHA
+$606K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$330K
5
GRNY
FundStrat Granny Shots US Large Cap ETF
GRNY
+$324K

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$2.11M
2
AAPL icon
Apple
AAPL
+$847K
3
XLG icon
Invesco S&P 500 Top 50 ETF
XLG
+$325K
4
RDVI icon
FT Vest Rising Dividend Achievers Target Income ETF
RDVI
+$285K
5
MSFT icon
Microsoft
MSFT
+$235K

Sector Composition

Rank Sector Weight
1 Technology 27.84%
2 Financials 15.73%
3 Industrials 12.04%
4 Real Estate 10.42%
5 Consumer Discretionary 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDXX icon
576
Idexx Laboratories
IDXX
$46.9B
$16.1K ﹤0.01%
30
– –
C icon
577
Citigroup
C
$227B
$15.9K ﹤0.01%
187
-246
-57% -$17.8K
VYM icon
578
Vanguard High Dividend Yield ETF
VYM
$83.7B
$15.9K ﹤0.01%
119
+1
+0.8% +$127
MRAM icon
579
Everspin Technologies
MRAM
$388M
$15.7K ﹤0.01%
2,500
– –
ABEO icon
580
Abeona Therapeutics
ABEO
$425M
$15.7K ﹤0.01%
2,759
+2,708
+5,310% +$15.4K
DMAC icon
581
DiaMedica Therapeutics
DMAC
$358M
$15.6K ﹤0.01%
+4,012
New +$15.6K
PTLO icon
582
Portillo's
PTLO
$325M
$15.6K ﹤0.01%
1,335
– –
ANET icon
583
Arista Networks
ANET
$242B
$15.6K ﹤0.01%
152
– –
MATV icon
584
Mativ Holdings
MATV
$706M
$15.4K ﹤0.01%
2,255
+8
+0.4% +$46
SMG icon
585
ScottsMiracle-Gro
SMG
$3.63B
$15.4K ﹤0.01%
233
– –
CVSA
586
Covista Inc
CVSA
$4.38B
$15K ﹤0.01%
118
– –
HQH
587
abrdn Healthcare Investors
HQH
$1.33B
$15K ﹤0.01%
968
– –
KALV
588
DELISTED
KalVista Pharmaceuticals
KALV
$15K ﹤0.01%
+1,324
New +$16.2K
AMN icon
589
AMN Healthcare
AMN
$1.42B
$14.7K ﹤0.01%
713
– –
PH icon
590
Parker-Hannifin
PH
$134B
$14.7K ﹤0.01%
21
– –
SHEL icon
591
Shell
SHEL
$249B
$14.6K ﹤0.01%
207
-213
-51% -$14.3K
HHH icon
592
Howard Hughes
HHH
$3.91B
$14.5K ﹤0.01%
215
– –
TARS icon
593
Tarsus Pharmaceuticals
TARS
$2.97B
$14.5K ﹤0.01%
+358
New +$16.1K
CDNS icon
594
Cadence Design Systems
CDNS
$91.4B
$14.5K ﹤0.01%
47
– –
ARGX icon
595
argenx
ARGX
$54.2B
$14.3K ﹤0.01%
26
– –
ORGO icon
596
Organogenesis Holdings
ORGO
$239M
$14.3K ﹤0.01%
+3,913
New +$14.6K
VTGN icon
597
VistaGen Therapeutics
VTGN
$11.7M
$14.3K ﹤0.01%
+7,155
New +$16.3K
VXF icon
598
Vanguard Extended Market ETF
VXF
$31.8B
$14.3K ﹤0.01%
74
-1
-1% -$178
PSX icon
599
Phillips 66
PSX
$86B
$14.1K ﹤0.01%
118
-177
-60% -$19.8K
MKL icon
600
Markel Group
MKL
$22.8B
$14K ﹤0.01%
7
– –
22 23
24
25 26

Similar funds

CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
TC
Triata Capital Hong Kong $552M AUM 2.89% 1-Year Est. Return
BT
Brandywine Trust Hockessin, Delaware $552M AUM 5.23% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
IQI
Integrated Quantitative Investments Bellevue, Washington $551M AUM 45.27% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return

Truvestments Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Truvestments Capital held 1,111 positions worth $500M, up 8.6% from $461M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Truvestments Capital's Q2 2025 filing shows 66 new, 187 increased, 301 reduced and 121 closed positions. Its largest new stake was FundStrat Granny Shots US Large Cap ETF: 16,250 shares worth $369K. The largest sale was Wells Fargo, an estimated $2.11M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 23% a quarter earlier, followed by Financials and Industrials.

  • Truvestments Capital's largest Q2 2025 buy was FundStrat Granny Shots US Large Cap ETF: 16,250 shares worth $369K.
  • Truvestments Capital added most to Strategy Inc in Q2 2025, an estimated $1.88M increase.
  • Truvestments Capital's biggest Q2 2025 reduction was Wells Fargo, cutting an estimated $2.11M.
  • Truvestments Capital fully exited Patterson Companies, Inc. in Q2 2025, selling an estimated $141K.
  • Truvestments Capital's ten largest holdings make up 27% of its $500M portfolio in Q2 2025.
  • Truvestments Capital opened 66 new positions and closed 121 in Q2 2025.
  • Truvestments Capital's portfolio value rose 8.6% quarter-over-quarter to $500M.

Based on Truvestments Capital's 13F filing for Q2 2025, filed 13 Aug 2025.